Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CFSAN Adverse Event Strategy: Will Notifying Industry Create A 2-Way Road?

Sep 02 2002

• By The Tan Sheet

Related Content

FDA Dietary Supplement Claims Oversight Will Be “More Aggressive” – Troy

Apr 22 2002

CFSAN/Poison Control Center Supplement AER Contract Recommended By OIG

Apr 23 2001

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window